Anti-D testing in intravenous immunoglobulins: Shouldn't it be considered? [4]

Vox Sanguinis

Volumn 71, Issue 2, 1996, Pages 132-

  Pisani, G ^a   Wirz, M ^a   Gentili, G ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; RHESUS D ANTIBODY; STEROID;

ANEMIA; ANTIBODY DETECTION; CASE REPORT; DRUG MEGADOSE; DRUG SCREENING; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LETTER; MALE; PRIORITY JOURNAL; SCHOOL CHILD; THROMBOCYTOPENIC PURPURA;

EID: 0029802048     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1423-0410.1996.7120132.x     Document Type: Letter

References (3)

1. 1 Nakamura S, Yoshida T, Ohtake S, Matsuda T: Hemolysis due to high‐dose intravenous treatment for patients with idiopathic thrombocytopenic purpura. Acta Haematol 1986 ; 76: 115–118.
2. 2 Copelan EA, Strohm PL, Kennedy MS, Tutschka PJ: Hemolysis following intravenous immune globulin therapy. Transfusion 1986 ; 26: 410–412.
3. 3 Salama A, Mueller‐Eckhardt C, Kiefel V: Effect of intravenous immunoglobulin in immune thrombocytopenia: Competitive inhibition of reticuloendothelial system function by sequestration of autologous red blood cells Lancet 1986 ; ii: 193–195.